Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Reprogramming T cells into NK-like cells for use in cancer immunotherapy via B-cell CLL/lymphoma 11B (BCL11B) deletion. Science-Business eXchange 3, 749 (2010). https://doi.org/10.1038/scibx.2010.749
Issue Date:
DOI: https://doi.org/10.1038/scibx.2010.749